Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

PAF antagonist safe but not effective in the treatment of ulcerative colitis

Jan. 13, 1999

Novel antiviral phenylpropenamide derivative for HBV

Jan. 12, 1999

Preclinical studies demonstrate mechanism of action, efficacy of anti-HBV agent

Jan. 12, 1999

Chinese authorities approve anti-HBV drug for marketing

Jan. 11, 1999

Sigma ligands synthesized at Jouveinal, evaluated and claimed for GI disorders

Jan. 8, 1999

Oxis announces initial results of phase IIa clinical trial in ulcerative colitis

Jan. 8, 1999

SciClone continues to receive and seek approvals for Zadaxin

Jan. 5, 1999

Antiulcer effects and mechanism of action of AU-006 explored

Jan. 4, 1999

NO donor effective in canine ischemic liver injury model

Dec. 30, 1998

FR-167653 proves effective against ischemic liver damage

Dec. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...